Precipio Net Total Equity Issued/Repurchased 2010-2024 | PRPO
Precipio net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
| Precipio Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2023 | $2 |
| 2022 | $0 |
| 2021 | $17 |
| 2020 | $9 |
| 2019 | $8 |
| 2018 | $3 |
| 2017 | $8 |
| 2016 | $ |
| 2015 | $9 |
| 2014 | $9 |
| 2013 | $8 |
| 2012 | $17 |
| 2011 | $0 |
| 2010 | $6 |
| 2009 | $ |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.015B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.209B | 54.83 |
| Hims & Hers Health (HIMS) | United States | $15.018B | 381.89 |
| Tempus AI (TEM) | United States | $13.495B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.303B | 103.31 |
| IRhythm Technologies (IRTC) | United States | $3.538B | 0.00 |
| Privia Health (PRVA) | United States | $3.060B | 255.00 |
| Enovis (ENOV) | United States | $2.533B | 16.87 |
| Clover Health Investments (CLOV) | United States | $2.280B | 0.00 |
| Azenta (AZTA) | United States | $2.075B | 96.64 |
| Schrodinger (SDGR) | United States | $1.895B | 0.00 |
| Omnicell (OMCL) | United States | $1.858B | 40.53 |
| Phreesia (PHR) | United States | $1.725B | 0.00 |
| 10x Genomics (TXG) | United States | $1.465B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.004B | 0.00 |
| Talkspace (TALK) | United States | $0.652B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| TruBridge (TBRG) | United States | $0.426B | 124.04 |
| Nyxoah SA (NYXH) | Belgium | $0.357B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.319B | 0.00 |
| Pulmonx (LUNG) | United States | $0.262B | 0.00 |
| American Well (AMWL) | United States | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Outset Medical (OM) | United States | $0.050B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.028B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |